Literature DB >> 9811772

Construction and characterization of hexon-chimeric adenoviruses: specification of adenovirus serotype.

J G Gall1, R G Crystal, E Falck-Pedersen.   

Abstract

This study has used the strategy of gene replacement to characterize the contribution of the adenovirus (Ad) capsid protein hexon to serotype definition. By replacing the Ad type 5 (Ad5) hexon gene with sequences from Ad2, we have changed the type specificity of the chimeric virus. The type-determining epitopes are primarily associated with loop 1 of hexon and, to a much lesser degree, with loop 2. In spite of the serotype distinctiveness of the chimeric hexon viruses, epitope similarity between the vectors resulted in a low level of cross-reactive neutralizing antibody, which in combination with activated cellular and innate arms of the immune system is sufficient to suppress gene transduction following readministration in vivo.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811772      PMCID: PMC110610     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Correlation of 140S antigen dose with the serum neutralizing antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines.

Authors:  T W Pay; P J Hingley
Journal:  Vaccine       Date:  1987-03       Impact factor: 3.641

2.  Structural proteins of adenoviruses. VI. On the antigenic determinants of the hexon.

Authors:  U Pettersson
Journal:  Virology       Date:  1971-01       Impact factor: 3.616

3.  Adenovirus hexon. Sequence comparison of subgroup C serotypes 2 and 5.

Authors:  R Kinloch; N Mackay; V Mautner
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

4.  Classification and nomenclature of viruses. Fourth report of the International Committee on Taxonomy of Viruses.

Authors: 
Journal:  Intervirology       Date:  1982       Impact factor: 1.763

5.  Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

Authors:  H Gahéry-Ségard; F Farace; D Godfrin; J Gaston; R Lengagne; T Tursz; P Boulanger; J G Guillet
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

6.  Virus-receptor interaction in the adenovirus system I. Identification of virion attachment proteins of the HeLa cell plasma membrane.

Authors:  U Svensson; R Persson; E Everitt
Journal:  J Virol       Date:  1981-04       Impact factor: 5.103

7.  Antigenic determinants of adenovirus capsids. II. Homogeneity of hexons, and accessibility of their determinants, in the virion.

Authors:  N Willcox; V Mautner
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

8.  The purification of adenovirus neutralizing antibody: adenovirus type 5 hexon immunoadsorbent.

Authors:  A T Haase; H G Pereira
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

9.  Three-dimensional structure of the adenovirus major coat protein hexon.

Authors:  M M Roberts; J L White; M G Grütter; R M Burnett
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

10.  Entry of adenovirus 2 into HeLa cells.

Authors:  U Svensson; R Persson
Journal:  J Virol       Date:  1984-09       Impact factor: 5.103

View more
  44 in total

1.  Identification of the hexon region of an adenovirus involved in a new outbreak of keratoconjunctivitis.

Authors:  Y Imai; S Kameya; M Ohkoshi; K Yamaki; S Sakuragi
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

2.  Construction and characterization of adenovirus serotype 5 packaged by serotype 3 hexon.

Authors:  Hongju Wu; Igor Dmitriev; Elena Kashentseva; Toshiro Seki; Minghui Wang; David T Curiel
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

3.  Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines.

Authors:  Dan H Barouch; Paul F McKay; Shawn M Sumida; Sampa Santra; Shawn S Jackson; Darci A Gorgone; Michelle A Lifton; Bimal K Chakrabarti; Ling Xu; Gary J Nabel; Norman L Letvin
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

4.  Neutralizing antibodies and CD8+ T lymphocytes both contribute to immunity to adenovirus serotype 5 vaccine vectors.

Authors:  Shawn M Sumida; Diana M Truitt; Michael G Kishko; Janelle C Arthur; Shawn S Jackson; Darci A Gorgone; Michelle A Lifton; Wouter Koudstaal; Maria G Pau; Stefan Kostense; Menzo J E Havenga; Jaap Goudsmit; Norman L Letvin; Dan H Barouch
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

5.  Phylogenetic analysis of the main neutralization and hemagglutination determinants of all human adenovirus prototypes as a basis for molecular classification and taxonomy.

Authors:  Ijad Madisch; Gabi Harste; Heidi Pommer; Albert Heim
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

Review 6.  Human immunodeficiency virus type 1 vaccine development: recent advances in the cytotoxic T-lymphocyte platform "spotty business".

Authors:  Kimberly A Schoenly; David B Weiner
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

7.  Identification of a suppressor mutation that improves the yields of hexon-modified adenovirus vectors.

Authors:  Joseph T Bruder; Ping Chen; Elena Semenova; Charlie A Thomas; Svetlana Konovalova; Greg Ekberg; Damodar Ettyreddy; Duncan McVey; Jason G Gall; C Richter King; Douglas E Brough
Journal:  J Virol       Date:  2013-07-03       Impact factor: 5.103

8.  Directed evolution of mutator adenoviruses resistant to antibody neutralization.

Authors:  Nicolle D Myers; Ksenia V Skorohodova; Anshu P Gounder; Jason G Smith
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

9.  Expression and serological reactivity of hemorrhagic enteritis virus hexon protein.

Authors:  Dana Lobová; Vladimír Celer
Journal:  Folia Microbiol (Praha)       Date:  2015-10-15       Impact factor: 2.099

10.  Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods.

Authors:  John J Rux; Paula R Kuser; Roger M Burnett
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.